CovidVax show full list

GBP510, recombinant surface protein with adjuvant AS03

SK Bioscience
(South Korea)
vaccine type: Protein subunit
Distribution updates
currently no distribution info
Human Testing updates (clinical trials)



started January 20 2021

with 260 healthy volunteers aged 19-85

trial location: South Korea

» clinical trial details

Feb 05SK Bioscience said it has begun conducting clinical studies on two COVID-19 vaccine candidates (by
Feb 04SK has started enrollment in a Phase 1/2 clinical trial for its COVID-19 vaccine supported by BMGF and CEPI (by
Mar 23SK's vaccine shows high safety and it's expected to start clinical trials in September (by
Animal Testing updates (pre-clinical trials)
start date: March 2020
Mar 24SK announced Monday that it will be testing its vaccine on rodents infected with the virus (by
early development updates
Dec 10SK has started to develop a COVID-19 vaccine that will be supplied to the world through global cooperation (by

Bill & Melinda Gates Foundation + CEPI

contact | about | ©2020 project